Outteridge P M, Lepper A W
Immunology. 1973 Dec;25(6):981-94.
Experiments were carried out in BCG-sensitized cattle to see if factors produced by transforming blood lymphocytes could modify the tuberculin skin reaction or the uptake of [H]thymidine by sensitized bovine lymphocytes. It was found that the subcutaneous injection on one side of the neck of tuberculin, tuberculin-stimulated autologous blood lymphocytes or culture supernates from tuberculin-stimulated lymphocytes depressed the response to intradermal injection of tuberculin on the other side. The suppression of the response appeared to be antigenically specific since the delayed skin reaction to the intradermal injection of brucallergen was not suppressed by the injection of the same lymphocyte culture supernates. studies of [H]thymidine uptake by autologous lymphocytes showed that the culture supernates from tuberculin-stimulated lymphocytes had a mitogenic activity, but at higher concentrations of supernate, this mitogenic activity was depressed. The higher concentration of supernate also non-specifically suppressed [H]thymidine uptake by autologous lymphocytes stimulated with phytohaemagglutinin or brucallergen. Since an immunosuppressive α-globulin fraction had been demonstrated in bovine serum by other workers, it was thought that this may have been the factor released by the transforming lymphocytes. The α-globulin fraction was therefore isolated from sera of four tuberculous cattle, obtained 10 days after tuberculin skin testing, and from four uninfected and untested control cows. This serum α-globulin fraction from both groups of cattle, suppressed [H]thymidine uptake by homologous lymphocytes stimulated with tuberculin or PHA but levels of this factor in sera of tuberculous cattle were not raised above those in control cattle. It was concluded that the antigenically-specific suppression of tuberculin skin-reactions was most likely mediated by antigen—antibody complexes. On the other hand results with cultured lymphocytes may have been due to a non-specific immunosuppressant released from lymphocytes and which had properties in common with a serum α-globulin fraction.
在卡介苗致敏的牛身上进行了实验,以观察转化血淋巴细胞产生的因子是否能改变结核菌素皮肤反应或致敏牛淋巴细胞对[H]胸腺嘧啶核苷的摄取。结果发现,在颈部一侧皮下注射结核菌素、结核菌素刺激的自体血淋巴细胞或结核菌素刺激淋巴细胞的培养上清液,会抑制另一侧皮内注射结核菌素的反应。这种反应的抑制似乎具有抗原特异性,因为注射相同的淋巴细胞培养上清液并不能抑制对皮内注射布鲁氏菌素的迟发型皮肤反应。对自体淋巴细胞摄取[H]胸腺嘧啶核苷的研究表明,结核菌素刺激淋巴细胞的培养上清液具有促有丝分裂活性,但在更高浓度的上清液中,这种促有丝分裂活性会受到抑制。更高浓度的上清液还非特异性地抑制了用植物血凝素或布鲁氏菌素刺激的自体淋巴细胞对[H]胸腺嘧啶核苷的摄取。由于其他研究人员已在牛血清中证实了一种免疫抑制性α球蛋白组分,因此认为这可能是转化淋巴细胞释放的因子。因此,从结核菌素皮肤试验10天后的4头患结核病牛的血清以及4头未感染且未进行试验的对照奶牛的血清中分离出了α球蛋白组分。两组牛的这种血清α球蛋白组分均抑制了用结核菌素或PHA刺激的同源淋巴细胞对[H]胸腺嘧啶核苷的摄取,但患结核病牛血清中该因子的水平并未高于对照牛。得出的结论是,结核菌素皮肤反应的抗原特异性抑制很可能是由抗原-抗体复合物介导的。另一方面,培养淋巴细胞的结果可能是由于淋巴细胞释放的一种非特异性免疫抑制剂,它与血清α球蛋白组分具有共同特性。